* AVITA Medical Inc RCEL.OQ reported a quarterly adjusted
loss
of 22 cents per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 29 cents per share.
* Revenue rose 36.3% to $9.46 million from a year ago;
analysts
expected $8.68 million.
* AVITA Medical Inc's reported EPS for the quarter was a
loss
of 22 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no negative revisions
of
earnings estimates
* AVITA Medical Inc shares had risen by 37.3% this quarter.
* The company reported a quarterly loss of $5.35 million.
* Wall Street's median 12-month price target for AVITA
Medical Inc
is $16.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data February
24 at 06:39 a.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.29 -0.22 Beat
Sep. 30 2022 -0.34 -0.22 Beat
Jun. 30 2022 -0.39 -0.25 Beat
Mar. 31 2022 -0.38 -0.38 Met